Innovations in cancer treatment enable therapies to be tailored to each person’s individual characteristics or symptoms, and how that person responds to treatment during all stages of care. This could potentially mean that patients can live longer and better lives with cancer. But such cutting-edge care comes at a steep price, and can Malaysians afford it? Dr Matin Mellor, Consultant Clinical Oncologist; and Professor Adrian Towse, Director Emeritus, Office of Health Economics, UK, share how Malaysia can use innovative financing approaches to expand access to precision medicine.

Image Source: Shutterstock 

Produced by: Tee Shiao Eek

Presented by: Tee Shiao Eek

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Health Policy,  Diseases & Conditions,  Mental Health,  Healthy Living,  Fitness,  Medical Innovation and Technology,  Science

Tags:  The Bigger Picture,  Health & Living,  Cancer,  Financing,  Targeted Therapy,  Immunotherapy,  Health Economics,